Bipartisan Pediatric Cancer Drug Research Bill Left Out Of Year-End Package

By Beth Wang / December 27, 2022 at 10:32 AM
A bipartisan bill that aimed to give FDA authority to require sponsors of pediatric cancer trials study a combination of drugs, rather than one drug at a time, in order to speed development of drugs that treat relapsed cancer did not make it into the year-end spending package. Reps. G. K. Butterfield (D-NC) and Michael McCaul’s (R-TX) Give Kids a Chance Act (H.R. 5416) was included in the House-passed user fee bill earlier this year, but it was pulled out...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.